{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T15:38:56Z","timestamp":1782833936019,"version":"3.54.5"},"reference-count":26,"publisher":"Oxford University Press (OUP)","issue":"8","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017,4,15]]},"DOI":"10.2146\/ajhp160200","type":"journal-article","created":{"date-parts":[[2017,4,7]],"date-time":"2017-04-07T10:45:13Z","timestamp":1491561913000},"page":"587-592","source":"Crossref","is-referenced-by-count":12,"title":["Probable interaction between levothyroxine and ritonavir: Case report and literature review"],"prefix":"10.1093","volume":"74","author":[{"given":"Rahul","family":"Sahajpal","sequence":"first","affiliation":[{"name":"Rocky View General Hospital, Calgary, Alberta, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rabia A.","family":"Ahmed","sequence":"additional","affiliation":[{"name":"Department of Medicine, University of Alberta, Edmonton, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine A.","family":"Hughes","sequence":"additional","affiliation":[{"name":"Faculty of Pharmacy & Pharmaceutical Sciences, University of Alberta, Edmonton, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michelle M.","family":"Foisy","sequence":"additional","affiliation":[{"name":"Northern Alberta Program, Royal Alexandra Hospital, Edmonton, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","reference":[{"key":"key\n\t\t\t\t2019041103222298600_b1-0740587","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.1089\/thy.2014.0028","article-title":"Guidelines for the treatment of hypothyroidism: prepared by the American Thyroid Association Task Force on Thyroid Hormone Replacement","volume":"24","author":"Jonklaas","year":"2014","journal-title":"Thyroid"},{"key":"key\n\t\t\t\t2019041103222298600_b2-0740587","volume-title":"Synthroid (levothyroxine sodium) prescribing information","year":"2011"},{"key":"key\n\t\t\t\t2019041103222298600_b3-0740587","volume-title":"Norvir (ritonavir) prescribing information","year":"2014"},{"key":"key\n\t\t\t\t2019041103222298600_b4-0740587","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1345\/aph.1K615","article-title":"Induction effects of ritonavir: implications for drug interactions","volume":"42","author":"Foisy","year":"2008","journal-title":"Ann Pharmacother"},{"key":"key\n\t\t\t\t2019041103222298600_b5-0740587","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1046\/j.1365-2125.1998.00749.x","article-title":"Effect of ritonavir on the pharmacokinetics of ethinyl estradiol in healthy female volunteers","volume":"46","author":"Ouellet","year":"1998","journal-title":"Br J Clin Pharmacol"},{"key":"key\n\t\t\t\t2019041103222298600_b6-0740587","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.clpt.2006.04.014","article-title":"Lopinavir\/ritonavir reduces lamotrigine plasma concentrations in healthy subjects","volume":"80","author":"Van der Lee","year":"2006","journal-title":"Clin Pharmacol Ther"},{"key":"key\n\t\t\t\t2019041103222298600_b7-0740587","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1345\/aph.1G418","article-title":"Possible interaction between lopinavir\/ritonavir and valproic acid exacerbates bipolar disorder","volume":"40","author":"Sheehan","year":"2006","journal-title":"Ann Pharmacother"},{"key":"key\n\t\t\t\t2019041103222298600_b8-0740587","doi-asserted-by":"crossref","first-page":"988","DOI":"10.4158\/EP12280.GL","article-title":"Clinical practice guidelines for hypothyroidism in adults: cosponsored by the American Association of Clinical Endocrinologists and the American Thyroid Association","volume":"18","author":"Garber","year":"2012","journal-title":"Endocr Pract"},{"key":"key\n\t\t\t\t2019041103222298600_b9-0740587","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1086\/519978","article-title":"Thyroid function abnormalities in HIV-infected patients","volume":"45","author":"Hoffmann","year":"2007","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t2019041103222298600_b10-0740587","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1089\/thy.2011.0087","article-title":"Guidelines of the American Thyroid Association for the diagnosis and management of thyroid disease during pregnancy and postpartum","volume":"21","author":"Stagnaro-Green","year":"2011","journal-title":"Thyroid"},{"key":"key\n\t\t\t\t2019041103222298600_b11-0740587","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1111\/j.1365-2125.1983.tb01466.x","article-title":"A link between liver microsomal enzyme activity and thyroid hormone metabolism in man","volume":"15","author":"Ohnhaus","year":"1983","journal-title":"Br J Clin Pharmacol"},{"key":"key\n\t\t\t\t2019041103222298600_b12-0740587","first-page":"2235","article-title":"Interaction between ritonavir and levothyroxine","volume":"12","author":"Tseng","year":"1998","journal-title":"AIDS"},{"key":"key\n\t\t\t\t2019041103222298600_b13-0740587","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1097\/01.aids.0000226969.96880.3c","article-title":"Dramatic interaction between levothyroxine and lopinavir\/ritonavir in a HIV-infected patient","volume":"20","author":"Touzot","year":"2006","journal-title":"AIDS"},{"key":"key\n\t\t\t\t2019041103222298600_b14-0740587","first-page":"18","article-title":"Interaction between levothyroxine and ritonavir-boosted amprenavir in human immunodeficiency virus infected patients","volume":"1378","author":"Ruellan","year":"2011","journal-title":"Reactions Weekly"},{"key":"key\n\t\t\t\t2019041103222298600_b15-0740587","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1177\/0091270009359524","article-title":"Dose-related reduction in bupropion plasma concentrations by ritonavir","volume":"50","author":"Park","year":"2010","journal-title":"J Clin Pharmacol"},{"key":"key\n\t\t\t\t2019041103222298600_b16-0740587","volume-title":"Tivicay (dolutegravir) prescribing information","year":"2014"},{"key":"key\n\t\t\t\t2019041103222298600_b17-0740587","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.7326\/0003-4819-117-12-1010","article-title":"Ferrous sulfate reduces thyroxine efficacy in patients with hypothyroidism","volume":"117","author":"Campbell","year":"1992","journal-title":"Ann Intern Med"},{"key":"key\n\t\t\t\t2019041103222298600_b18-0740587","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1097\/GCO.0000000000000226","article-title":"Thyroid disorders in pregnancy","volume":"27","author":"Yalamanchi","year":"2015","journal-title":"Curr Opin Obstet Gynecol"},{"key":"key\n\t\t\t\t2019041103222298600_b19-0740587","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1345\/aph.1H423","article-title":"Proposal for a new tool to evaluate drug interaction cases","volume":"41","author":"Horn","year":"2007","journal-title":"Ann Pharmacother"},{"key":"key\n\t\t\t\t2019041103222298600_b20-0740587","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1097\/QAI.0b013e31818ce835","article-title":"Thyroid dysfunction and relationship to antiretroviral therapy in HIV-positive individuals in the HAART era","volume":"50","author":"Nelson","year":"2009","journal-title":"J Acquir Immune Defic Syndr"},{"key":"key\n\t\t\t\t2019041103222298600_b21-0740587","first-page":"743597","article-title":"Graves\u2019 disease as a manifestation of immune reconstitution in HIV-infected individuals after initiation of highly active antiretroviral therapy","volume":"2011","author":"Rasul","year":"2011","journal-title":"AIDS Res Treat"},{"key":"key\n\t\t\t\t2019041103222298600_b22-0740587","first-page":"452","article-title":"Case reports of three hypothyroid patients requiring very high doses of levothyroxine","volume":"5","author":"Ekpebegh","year":"2014","journal-title":"J Med Cases"},{"key":"key\n\t\t\t\t2019041103222298600_b23-0740587","first-page":"393","article-title":"Progression of autoimmune thyroiditis in an HIV-infected woman on HAART","volume":"9","author":"Rosenfeld","year":"1999","journal-title":"AIDS Read"},{"key":"key\n\t\t\t\t2019041103222298600_b24-0740587","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1086\/376626","article-title":"Increased prevalence of hypothyroidism among human immunodeficiency virus\u2013infected patients: a need for screening","volume":"37","author":"Beltran","year":"2003","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t2019041103222298600_b25-0740587","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1089\/thy.2012.0055","article-title":"Hashimoto\u2019s thyroiditis presenting as acute painful thyroiditis and as a manifestation of an immune reconstitution inflammatory syndrome in a human immunodeficiency virus\u2013seropositive patient","volume":"22","author":"Visser","year":"2012","journal-title":"Thyroid"},{"key":"key\n\t\t\t\t2019041103222298600_b26-0740587","volume-title":"Tybost (cobicistat) prescribing information","year":"2012"}],"container-title":["American Journal of Health-System Pharmacy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/ajhp\/article-pdf\/74\/8\/587\/28337263\/ajhp0587.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,20]],"date-time":"2019-09-20T19:35:24Z","timestamp":1569008124000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ajhp\/article\/74\/8\/587\/5103380"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,4,15]]},"references-count":26,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2017,4,15]]}},"URL":"https:\/\/doi.org\/10.2146\/ajhp160200","relation":{},"ISSN":["1079-2082","1535-2900"],"issn-type":[{"value":"1079-2082","type":"print"},{"value":"1535-2900","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2012,4,15]]},"published":{"date-parts":[[2012,4,15]]}}}